medical cannabis
medical cannabis · page 5
- Medical Cannabis
Do 10 Doctors Really Prescribe Half of England’s Medical Cannabis?
The UK’s medical cannabis market has long been a locked box when it comes to reliable data.
- Interviews
From Land to Brand: Why Cannabis’s Next Generation Is Going Asset-Light
Last year (fiscal year 2024/2025), Canada’s legal cannabis industry recorded revenues of CA$5.5bn, according to the latest figures from Statistics Canada.
- Data & Analysis
Public Data is No Longer Enough to Understand the German Medical Cannabis Market
Germany’s medical cannabis market, which has long been the engine powering Europe’s wider market growth, once again finds itself in a state of flux.
- International Regulation
Stop Consulting, Start Implementing: South Africa’s Cannabis Industry Demands Action as Businesses Suffer
South Africa’s long-suffering cannabis operators have demanded that the government make good on its extensive plans for a regulated framework, as frustration with its lack of meaningful action reaches a boiling point.
- Opinion
Europe’s Medical Cannabis Market Has Grown Up, Now Its Supply Chain Needs To
Written by Oskar Fletcher, Chief Executive of pharmaceutical contract manufacturing operator Blossom Pharma.
- Investment & Finance
Cannabis at an Inflexion Point: Why Capital Is Missing the Opportunity
For much of the past five years, the cannabis industry has been defined by disappointment.
- Medical Cannabis
Vertanical Secures Milestone FDA Breakthrough Designation for Cannabis Pain Drug Ahead of Imminent European Launch
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to VER-01, the flagship full-spectrum cannabis drug from Munich-based Vertanical, putting it in prime position to become the first FDA-approved cannabis-derived medicine for pain, and only the second such approval since Epidiolex in 2018.
- Events
Business of Cannabis Awards 2026: Our Esteemed Winners
As the sun finally dipped over London on the hottest day of the year, the buzz that had filled the Barbican throughout the first day of Cannabis Europa London 2026 moved a few streets east to 83 Rivington, as the tone shifted from debate to celebration.
- Interviews
Voices of Cannabis Europa: Philip Schetter, Joshua Cuby and Gabriel Newman, Cantourage
Cannabis Europa London returns on 26-27 May 2026, bringing together operators, investors, clinicians and policymakers from across the global cannabis industry for two days of main stage debate, exhibition, and networking.
- Opinion
From Green Success to BH Labs: Why the Next Cannabis Leaders Will Look More Like Technology Companies
As Europe’s medical cannabis market matures, a new category of operator is beginning to emerge.
- Industry Trends
Jersey’s Cannabis Industry Posts First Profit as Exports Triple, But the Real Value Is Still Leaving the Island
Jersey’s medical cannabis industry turned a profit for the first time in 2025, posting revenues of £12m, almost £50m in cumulative investment, and exports of nearly seven tonnes.
- Supply Chain
UK Medical Cannabis Imports Hit 30 Tonnes as Canadian Producers Bypass European Processors
Canadian producers shipped 17,067kg of medical cannabis directly to the UK in 2025, more than six times the 2,578kg recorded the year before, according to the latest official Home Office data seen by Business of Cannabis.
